men with a family history of prostate cancer have an increased risk, and higher incidence, disease progression, and mortality rates are observed among men of African descent compared to other racial groups [7][8][9][10][11].The development and progression of prostate cancer is often coupled with various genetic and chromosomal abnormalities, with breast cancer susceptibility gene 2 (BRCA2) mutation being one of the most critical genetic risk factors [12]. Mutations in the BRCA2 gene, a pivotal tumor suppressor involved in DNA damage repair, result in a loss of DNA reparative function, increasing genomic instability and ultimately promoting tumor development and progression [13]. Studies have shown that BRCA2 mutations not only raise the risk of prostate cancer but are also associated with greater tumor aggressiveness and a poorer prognosis [12, 14]. In addition, altered chromosome structure is a major pathologic feature of prostate